Riddhiben Patel
Neurology with Special Qualifications in Child Neurology · Cedar Park, TXNPI 1669728028
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,337 of the $2,836 with a category attached, or 82.4%. It is spread thinly across 29 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $27.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Irras USA, Inc.$499
- UCB, Inc.$485
- Corium, LLC$475
- SK Life Science, Inc.$183
- Supernus Pharmaceuticals, Inc.$122
- Tris Pharma Inc$96
- plus $976 from 23 others
Across 26 payments — averaging $3323.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$56K
- Upsher-smith Laboratories LLC$30K
What the payments were for
- Speaking & faculty fees$49918%
- Food & beverage$2,33782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Irras USA, Inc. | 1 | $499 |
| UCB, Inc. | 21 | $485 |
| Corium, LLC | 20 | $475 |
| SK Life Science, Inc. | 7 | $183 |
| Supernus Pharmaceuticals, Inc. | 7 | $122 |
| Tris Pharma Inc | 5 | $96 |
| AbbVie | 1 | $91 |
| Jazz Pharmaceuticals Inc. | 3 | $83 |
| Biogen | 3 | $82 |
| Noven Therapeutics, LLC | 3 | $62 |
| Eisai Inc. | 3 | $61 |
| PTC Therapeutics, Inc. | 3 | $59 |
| Neos Therapeutics, LP | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| Novartis | 1 | $39 |
| Pyros Pharmaceuticals, Inc. | 1 | $39 |
| Greenwich Biosciences, Inc. | 2 | $39 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| Neurelis, Inc. | 2 | $38 |
| Catalyst Pharmaceuticals, Inc. | 2 | $37 |
| ITF Therapeutics LLC | 1 | $34 |
| Springworks Therapeutics, Inc. | 2 | $33 |
| AstraZeneca | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| Aquestive Therapeutics, Inc. | 1 | $20 |
| Travere Therapeutics, Inc. | 1 | $17 |
| Livanova USA, Inc. | 1 | $16 |
| Aprecia Pharmaceuticals, LLC | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IRRASflow$499
How this compares
$2,836 in reported general payments places this provider in the 70th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Cedar Park
- Lindsay EltonCedar Park$8K
- Ryan BoeckCedar Park$6K
- Roy EltermanDallas$5.9M
- Huda ZoghbiHouston$5.5M
- Diana CastroDenton$343K
- Shade MoodyHouston$194K
- Mary Kay KoenigHouston$171K
- Michael PerryFort Worth$162K
- Raphael SchiffmannDallas$88K
- Mauricio Delgado-AyalaDallas$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.